A Nucleus-Imaging Probe That Selectively Stabilizes a Minor Conformation of C-MYC G-quadruplex and Down-regulates C-MYC Transcription in Human Cancer Cells
Affiliations
The c-MYC proto-oncogene is a regulator of fundamental cellular processes such as cell cycle progression and apoptosis. The development of novel c-MYC inhibitors that can act by targeting the c-MYC DNA G-quadruplex at the level of transcription would provide potential insight into structure-based design of small molecules and lead to a promising arena for cancer therapy. Herein we report our finding that two simple bis-triazolylcarbazole derivatives can inhibit c-MYC transcription, possibly by stabilizing the c-MYC G-quadruplex. These compounds are prepared using a facile and modular approach based on Cu(I) catalysed azide and alkyne cycloaddition. A carbazole ligand with carboxamide side chains is found to be microenvironment-sensitive and highly selective for "turn-on" detection of c-MYC quadruplex over duplex DNA. This fluorescent probe is applicable to visualize the cellular nucleus in living cells. Interestingly, the ligand binds to c-MYC in an asymmetric fashion and selects the minor-populated conformer via conformational selection.
Fatma K, Thumpati P, Panda D, Velayutham R, Dash J ACS Med Chem Lett. 2024; 15(3):388-395.
PMID: 38505840 PMC: 10945540. DOI: 10.1021/acsmedchemlett.3c00537.
Molecular Insights into the Specific Targeting of G-Quadruplex by Thiazole Peptides.
Cao S, Su Q, Chen Y, Wang M, Xu Y, Wang L Int J Mol Sci. 2024; 25(1).
PMID: 38203794 PMC: 10778990. DOI: 10.3390/ijms25010623.
Kamzeeva P, Dagaev N, Lizunova S, Khodarovich Y, Sogomonyan A, Kolchanova A Biomolecules. 2023; 13(11).
PMID: 38002351 PMC: 10669118. DOI: 10.3390/biom13111669.
Long W, Zheng B, Li Y, Huang X, Lin D, Chen C Nucleic Acids Res. 2022; 50(4):1829-1848.
PMID: 35166828 PMC: 8887543. DOI: 10.1093/nar/gkac090.
Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox.
Kretzmann J, Irving K, Smith N, Evans C NAR Cancer. 2022; 3(4):zcab048.
PMID: 34988459 PMC: 8693572. DOI: 10.1093/narcan/zcab048.